论文部分内容阅读
目的:探讨小儿心肺脑复苏中纳洛酮的应用效果。方法:选择本院2013年1月-2015年1月收治的100例小儿心肺脑复苏患者为研究对象,随机将其分为对照组和观察组,对照组观察对象接受常规心肺脑复苏治疗,观察组观察对象在此基础上接受纳洛酮治疗,对比分析两组患者的临床治疗效果。结果:观察组小儿心肺脑复苏患者临床治疗后存活率、复苏成功率、自主呼吸恢复时间和比例、自主循环恢复时间和比例等临床疗效指标均明显优于对照组(P<0.05),同时,观察组患者临床治疗后清醒时间(GCS)评分、急性生理与慢性健康评分(APACHE II)评分、β内啡肽(β-EP)和血乳酸等观察指标水平均明显优于对照组(P<0.05)。结论:小儿心肺脑复苏患者在常规心肺脑复苏治疗的基础上,接受纳洛酮治疗,有助于相关临床指标水平的改善,以及临床治疗效果的巩固。
Objective: To investigate the effect of naloxone on cardiopulmonary resuscitation in children. Methods: A total of 100 children with cardiopulmonary resuscitation admitted to our hospital from January 2013 to January 2015 were enrolled in this study. Patients were randomly divided into control group and observation group. The control group received routine cardiopulmonary resuscitation. On the basis of this observation, the subjects were treated with naloxone, and the clinical effects of the two groups were compared. Results: The clinical efficacy indexes of survival rate, success rate of resuscitation, spontaneous breathing recovery time and proportion, time and ratio of spontaneous circulation recovery in observation group were significantly better than those in control group (P <0.05) The scores of GCS, APACHE II, β-EP and BLA in the observation group were significantly better than those in the control group (P < 0.05). Conclusion: Pediatric cardiopulmonary resuscitation patients receiving naloxone on the basis of conventional cardiopulmonary resuscitation may help to improve the level of related clinical indicators and consolidate the clinical effect.